Tue, August 17, 2021

Katie Tryhane Initiated (SOPH) at Buy and Held Target at $22 on, Aug 17th, 2021

Katie Tryhane of Credit Suisse, Initiated "SOPHiA GENETICS SA" (SOPH) at Buy and Held Target at $22 on, Aug 17th, 2021.

Katie, nor any peers, have made any analyst calls on SOPH in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30